CoverageForm 410-K10-Q8-K13D13G13F

IOSP · Innospec Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · IOSP

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$453.20M-$441.90M$439.70M$440.80M-$443.40M$435.00M$500.20M-
Cost of Revenue$329.70M-$325.20M$316.50M$315.70M-$319.30M$308.10M$344.50M-
Gross Profit$123.50M-$116.70M$123.20M$125.10M-$124.10M$126.90M$155.70M-
R&D$13.20M-$13.70M$13.60M$12.70M-$11.10M$12.20M$11.80M-
SG&A$78.50M-$71.90M$74.60M$69.30M-$66.80M$73.40M$92.70M-
Total Operating Expenses$87.00M-$110.80M$88.90M$82.60M-$78.50M$86.20M$105.20M-
D&A$9.90M---$10.90M---$10.40M-
Operating Income$36.50M-$5.90M$34.30M$42.50M-$45.60M$40.70M$50.50M-
Interest Expense----------
Income Tax$9.10M-($1.40M)$8.40M$11.60M-$11.40M$12.50M$13.90M-
Net Income$30.40M-$12.90M$23.50M$32.80M-$33.40M$31.20M$41.40M-
EPS - Basic$1.23-$0.52$0.94$1.31-$1.34$1.25$1.66-
EPS - Diluted$1.22-$0.52$0.94$1.31-$1.33$1.24$1.65-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$289.10M$292.50M$270.80M$266.60M$299.80M$289.20M$303.80M$240.20M$270.10M$203.70M
Accounts Receivable$354.20M$342.30M$349.50M$336.10M$343.50M$341.70M$327.60M$300.30M$318.20M$359.80M
Inventory$321.50M$329.30M$345.20M$336.80M$315.40M$301.00M$319.30M$313.50M$304.30M$300.10M
Accounts Payable$138.50M$174.70M$162.20M$149.40M$169.50M$163.80M$169.00M$147.70M$166.40M$163.60M
Current Assets$999.10M$1.00B$988.80M$969.70M$977.10M$956.60M$965.60M$876.80M$912.90M$885.70M
Total Assets$1.82B$1.83B$1.80B$1.81B$1.77B$1.73B$1.80B$1.70B$1.73B$1.71B
Current Liabilities$334.80M$360.10M$356.10M$337.40M$357.60M$371.40M$373.10M$332.80M$364.90M$371.50M
Long-term Debt----------
Total Liabilities$467.60M$499.50M$496.50M$504.60M$508.90M$518.60M$550.10M$504.40M$546.60M$557.80M
Stockholders' Equity$1.34B$1.33B$1.30B$1.30B$1.26B$1.21B$1.24B$1.19B$1.18B$1.15B
Retained Earnings$1.13B$1.10B$1.07B$1.06B$1.06B$1.02B$1.12B$1.08B$1.07B$1.03B

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$17.60M---$28.30M---$80.60M-
Investing Cash Flow($13.70M)---($15.50M)---($14.30M)-
Financing Cash Flow($6.60M)---($3.80M)---$500.0K-
CapEx----------
Free Cash Flow----------

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin27.3%-26.4%28.0%28.4%-28.0%29.2%31.1%-
Operating margin8.1%-1.3%7.8%9.6%-10.3%9.4%10.1%-
EBITDA margin10.2%---12.1%---12.2%-
Net margin6.7%-2.9%5.3%7.4%-7.5%7.2%8.3%-
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue2.9%-3.1%3.1%2.9%-2.5%2.8%2.4%-
SG&A / Revenue17.3%-16.3%17.0%15.7%-15.1%16.9%18.5%-
Effective tax rate23.0%--12.2%26.3%26.1%-25.4%28.6%25.1%-
Return on assets1.7%-0.7%1.3%1.8%-1.9%1.8%2.4%-
Return on equity2.3%-1.0%1.8%2.6%-2.7%2.6%3.5%-
Return on invested capital----------
Liquidity
Current ratio2.982.792.782.872.732.582.592.632.502.38
Quick ratio2.021.881.811.881.851.771.731.691.671.58
Cash ratio0.860.810.760.790.840.780.810.720.740.55
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier1.351.381.391.391.411.431.451.431.461.49
Liabilities / Assets0.260.270.280.280.290.300.310.300.320.33
Efficiency
Asset turnover0.25-0.250.240.25-0.250.260.29-
Inventory turnover1.03-0.940.941.00-1.000.981.13-
Days sales outstanding285d-289d279d284d-270d252d232d-
Days inventory outstanding356d-387d388d365d-365d371d322d-
Days payable outstanding153d-182d172d196d-193d175d176d-
Cash conversion cycle488d-494d495d453d-441d448d378d-
Valuation
P / E59.9x-148.4x89.5x72.3x-85.0x99.7x78.1x-
P / B1.3x-1.5x1.6x1.9x-2.3x2.6x2.7x-
P / S4.0x-4.3x4.8x5.4x-6.4x7.1x6.5x-
EV / EBITDA32.9x---38.9x---48.6x-
Growth
Revenue growth (YoY)2.8%--0.3%1.1%-11.9%--4.5%-9.5%-1.8%-
Revenue CAGR (3y)-3.8%--4.9%-2.0%-2.3%-5.6%7.1%--
Revenue CAGR (5y)--10.8%12.4%3.4%-3.6%3.7%5.2%-
Gross profit growth (YoY)-1.3%--6.0%-2.9%-19.7%--9.5%-15.6%5.3%-
Operating income growth (YoY)-14.1%--87.1%-15.7%-15.8%-8.8%19.0%23.2%-
Net income growth (YoY)-7.3%--61.4%-24.7%-20.8%--14.8%8.0%24.7%-
EPS growth (YoY)-6.9%--60.9%-24.2%-20.6%--15.3%6.9%24.1%-
EPS CAGR (3y)-2.8%--30.5%-10.0%-3.5%-12.3%11.3%--
EPS CAGR (5y)--0.4%--0.5%-1.7%6.6%7.1%-
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)6.7%9.5%4.3%8.6%6.5%5.6%10.5%9.2%9.8%10.5%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$1.31B total
Fuel Specialties$509.40M · 38.8%
Performance Chemicals$409.20M · 31.1%
Oilfield Services$395.10M · 30.1%

Geographic

$2.12B total
US$951.70M · 44.8%
GB$793.20M · 37.3%
Rest Of World$379.00M · 17.8%

Peer comparison

Same SIC group: Chemicals & Allied Products

CompanyRevenue (last FY)Net marginROE
FMC$3.47B-64.6%-108.1%
CC$5.81B-6.6%-154.4%
OLN$6.78B-1.5%-5.5%
NGVT$1.17B-14.3%-562.6%
HUN$6.04B-3.1%-6.9%

Comparing INNOSPEC INC. against the 5 most active filers in the same SIC group.

Dividends

$1.79/share trailing 12 months · +9.8% YoY

Ex-datePer share
May 19, 2026$0.9200
Nov 18, 2025$0.8700
May 20, 2025$0.8400
Nov 18, 2024$0.7900
May 17, 2024$0.7600
Nov 17, 2023$0.7200
May 19, 2023$0.6900
Nov 18, 2022$0.6500
May 16, 2022$0.6300
Nov 15, 2021$0.5900
May 14, 2021$0.5700
Nov 16, 2020$0.5200
May 15, 2020$0.5200
Nov 18, 2019$0.5200
May 20, 2019$0.5000
Nov 16, 2018$0.4500
May 18, 2018$0.4400
Nov 15, 2017$0.3900
May 18, 2017$0.3800
Nov 10, 2016$0.3400
May 12, 2016$0.3300
Nov 12, 2015$0.3100
May 14, 2015$0.3000
Nov 13, 2014$0.2800